-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
It has long been known that the correct timing of embryo transfer is critical to the chance of pregnancy
However, it is still a challenge to accurately determine the right moment of a woman's menstrual cycle, which has led to a very low success rate of IVF, which is still less than 50% on average
But now researchers at RMIT University may have found a way forward.
The research team found that the level of this molecule on the surface of the uterus drops at a certain point in the menstrual cycle
This makes the uterus more viscous, opening the "golden window" for a successful pregnancy
Previously, scientists believed that implantation depends on molecules that actively promote the adhesion of the embryo to the uterine wall
Lead researcher Professor Guiying Nie said that the team’s findings have changed the scientific thinking about embryo implantation for a long time
She said: "We have been looking for substances that help embryos to adhere, but the key part of this puzzle turned out to be a slippery molecule that has the opposite effect-preventing embryos from adhering
Studies have found that there is a significant difference in the success rate of IVF when the embryo is present or absent on the surface of the uterus
"For infertile families, every embryo is precious, so choosing the right time is very important," said Nie, head of the Implantation and Pregnancy Research Laboratory at the School of Health and Biomedicine, RMIT University.
"We hope that through further research, our findings can help clinicians accurately determine when each patient is most likely to become pregnant, and provide a completely personalized IVF treatment
The results of this study, published in the journal Fertility and Infertility and Human Reproduction, may have a significant impact on IVF treatments and success rates
Pregnancy success rate
This retrospective clinical study was jointly designed by Nie and Professor Luk Rombauts of Monash IVF.
Uterine biopsy is performed in the middle of the luteal phase of the female menstrual cycle (about 7 days after ovulation), a complete cycle before the transfer of frozen embryos
The pregnancy success rate of women with low PCX levels is 53%, while the pregnancy success rate of women with no reduction in PCX molecules is only 18%
Rombauts said that measuring the level of PCX in the mid-luteal phase can be used as a screening test, but it may also indicate the cause of infertility, making this molecule a potential therapeutic target
He said: "These findings provide us with a promising path, which can both improve the success rate of in vitro fertilization and potentially treat the underlying causes of infertility
.
"
The research team has begun to better understand the role of PCX and how it is regulated in the body, with the goal of developing treatments for infertility
.
Nie said that this molecular analysis can be performed in a standard pathology laboratory, which makes future screening tests relatively cost-effective
.
"The only way we currently detect PCX is through tissue biopsy, which cannot be performed during embryo transfer," she said
.
"We need further research to develop a non-invasive real-time method for measuring PCX on the day of embryo transfer
.
"We hope to provide a simple test that can help patients and improve the accuracy and personalization of IVF treatment
.
"
This technology has been patented, and Monash IVF collaborators are further evaluating its potential clinical applications
.
Journal References :
Sophea Heng, Nirukshi Samarajeewa, Asma Aberkane, Wafaa Essahib, Hilde Van de Velde, Maxine Scelwyn, M.
Louise Hull, Beverley Vollenhoven, Luk J.
Rombauts, Guiying Nie.
Podocalyxin inhibits human embryo implantation in vitro and xinmetal podocacept.
is associated with implantation failure in fertility treatment .
Fertility and Sterility , 2021; DOI: 10.
1016/j.
fertnstert.
2021.
06.
028Sarah G Paule, Sophea Heng, Nirukshi Samarajeewa, Ying Li, Mary Mansilla, Andrew I Webb, Thomas Nebl, Steven L Young, Bruce A Lessey, M Louise Hull, Maxine Scelwyn, Rebecca Lim, Beverley Vollenhoven, Luk J Rombauts, Guiying Nie .
Podocalyxin is a key negative regulator of human endometrial epithelial receptivity for embryo implantation .
Human Reproduction , 2021; 36 (5): 1353 DOI: 10.
1093/humrep/deab032